1-甲基-4-(苯磺酰)哌嗪 | 66739-87-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 1-甲基-4-(苯磺酰)哌嗪
• 英文名称: 1-methyl-4-(phenylsulfonyl)piperazine
• 英文别名: 1-(benzenesulfonyl)-4-methylpiperazine
• CAS: 66739-87-5
• 化学式: C₁₁H₁₆N₂O₂S
• mdl: MFCD00519722
• 分子量: 240.326
• InChiKey: NCKYKYNYJREWCI-UHFFFAOYSA-N

物化性质

• 熔点：
  129-130 °C
• 沸点：
  363.7±52.0 °C(Predicted)
• 密度：
  1.227±0.06 g/cm3(Predicted)
• 溶解度：
  34.6 [ug/mL]

计算性质

• 辛醇/水分配系数(LogP)：
  0.9
• 重原子数：
  16
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.454
• 拓扑面积：
  49
• 氢给体数：
  0
• 氢受体数：
  4

安全信息

• 海关编码：
  2933599090

反应信息

• 作为反应物：
  描述：

  1-甲基-4-(苯磺酰)哌嗪 在 三甲基氯硅烷 、 sodium iodide 作用下， 以 乙腈 为溶剂， 反应 3.0h， 以74%的产率得到N-甲基哌嗪
  参考文献：
  名称：

  Deprotection of sulfonamides using iodotrimethylsilane

  摘要：

  The deprotection of sulfonamides is achieved under neutral conditions by reaction with iodotrimethylsilane in acetonitrile at reflux. (C) 1999 Published by Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0040-4039(98)02646-x
• 作为产物：
  描述：

  1-(4-溴苯基磺酰基)-4-甲基哌嗪 在 三乙基硅烷 、 cesium hydroxide 、 2-二叔丁基膦-2′,4′,6′-三异丙基-3,6-二甲氧基-1,1′-联苯 、 C₄₄H₆₂NO₅PPdS 、 1,3-双(二苯基膦)丙烷 、 palladium diacetate 、 三乙胺 作用下， 以 1,4-二氧六环 、 二氯甲烷 、 水 、 N,N-二甲基甲酰胺 为溶剂， 反应 24.75h， 生成 1-甲基-4-(苯磺酰)哌嗪
  参考文献：
  名称：

  A Fluorinated Ligand Enables Room-Temperature and Regioselective Pd-Catalyzed Fluorination of Aryl Triflates and Bromides

  摘要：

  A new biaryl monophosphine ligand (AlPhos, L1) allows for the room-temperature Pd-catalyzed fluorination of a variety of activated (hetero)aryl trifiates. Furthermore, aryl triflates and bromides that are prone to give mixtures of regioisomeric aryl fluorides with Pd-catalysis can now be converted to the desired aryl fluorides with high regioselectivity. Analysis of the solid-state structures of several Pd(II) complexes, as well as density functional theory (DFT) calculations, shed light on the origin of the enhanced reactivity observed with L1.

  DOI：

  10.1021/jacs.5b09308

文献信息

• Three-component synthesis of N-sulfonylformamidines in the presence of magnetic cellulose supported N-heterocyclic carbene-copper complex, as an efficient heterogeneous nanocatalyst
  作者：Salman Shojaei、Zarrin Ghasemi、Aziz Shahrisa

  DOI：10.1016/j.tetlet.2017.08.075

  日期：2017.10

  A cellulose based magnetic nanocomposite possessing NHC-Cu Complex has been synthesized and characterized. It was then applied as a highly active catalyst in one-pot three-component reaction of sulfonyl azides, secondary amines and triethylamine to afford N-sulfonylformamidines. Copper catalyzed oxidative transformation of C-N bond of triethylamine is a key step to give desired products. In contrast

  已经合成并表征了具有NHC-Cu配合物的纤维素基磁性纳米复合材料。然后将其用作高活性催化剂，用于磺酰叠氮化物，仲胺和三乙胺的一锅三组分反应，得到N-磺酰基甲am。铜催化三乙胺的CN键的氧化转化是获得所需产物的关键步骤。与常规仲胺的良好反应性相反，芳族胺和含NH的杂芳族化合物在这些反应中没有活性。而且，所使用的可以被外磁体回收的纳米催化剂多次显示出合理的催化活性。
• FUNCTIONALLY-MODIFIED OLIGONUCLEOTIDES AND SUBUNITS THEREOF
  申请人：Sarepta Therapeutics, Inc.

  公开号：US20140330006A1

  公开（公告）日：2014-11-06

  Functionally-modified oligonucleotide analogues comprising modified intersubunit linkages and/or modified 3′ and/or 5′-end groups are provided. The disclosed compounds are useful for the treatment of diseases where inhibition of protein expression or correction of aberrant mRNA splice products produces beneficial therapeutic effects.

  提供了包含修改的亚单位间连接和/或修改的3'和/或5'-末端基团的功能修饰寡核苷酸类似物。所公开的化合物对于治疗需要抑制蛋白质表达或纠正异常mRNA剪接产物以产生有益治疗效果的疾病是有用的。
• Facile One-Pot Synthesis of Aromatic and Heteroaromatic Sulfonamides
  作者：Rina Pandya、Takashi Murashima、Livio Tedeschi、Anthony G. M. Barrett

  DOI：10.1021/jo034643j

  日期：2003.10.1

  A series of arene and heteroarene sulfonamides were prepared in one vessel from aryl and heteroaryl bromides via conversion into the corresponding Grignard reagents using either magnesium or isopropylmagnesium chloride and subsequent reaction with sulfur dioxide, sulfuryl chloride, and an amine.

  在一个容器中，由芳基和杂芳基溴化物通过使用镁或异丙基氯化镁转化为相应的格氏试剂，然后与二氧化硫，硫酰氯和胺反应，制备了一系列芳烃和杂芳基磺酰胺。
• Sulfonamide Synthesis through Electrochemical Oxidative Coupling of Amines and Thiols
  作者：Gabriele Laudadio、Efstathios Barmpoutsis、Christiane Schotten、Lisa Struik、Sebastian Govaerts、Duncan L. Browne、Timothy Noël

  DOI：10.1021/jacs.9b02266

  日期：2019.4.10

  continuous development of novel and efficient synthetic methods to access these functional groups. Herein, we report an environmentally benign electrochemical method which enables the oxidative coupling between thiols and amines, two readily available and inexpensive commodity chemicals. The transformation is completely driven by electricity, does not require any sacrificial reagent or additional catalysts

  磺酰胺是药物和农用化学品中的关键基序，推动了对获取这些官能团的新型有效合成方法的不断开发。在此，我们报告了一种环境友好的电化学方法，该方法可以实现硫醇和胺之间的氧化偶联，这两种容易获得且价格低廉的商品化学品。转化完全由电力驱动，不需要任何牺牲试剂或额外的催化剂，只需5分钟即可完成。氢气在对电极处作为良性副产物形成。由于反应条件温和，该反应显示出广泛的底物范围和官能团兼容性。
• ANTI-CANCER ACTIVITY OF NOVEL BICYCLIC HETEROCYCLES
  申请人：Herman Jean

  公开号：US20140088088A1

  公开（公告）日：2014-03-27

  The present invention relates to compound of formula I, II, III, or IV, and/or a pharmaceutical acceptable addition salt thereof and/or a stereoisomer thereof and/or a solvate thereof, Formulas (I), (II), (III) and (IV) wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , R 11 , and R 12 are as defined in the claim 1 or as described in detail in the description of the invention, and to the use of said compounds to treat or prevent proliferative disorders and their use to manufacture a medicine to treat or prevent proliferative disorders, particularly cancer such as leukemia. The present invention also relates to pharmaceutical compositions of said compounds and the use of said pharmaceutical compositions to treat or prevent proliferative disorders. The present invention further relates to the use of said compounds as biologically active ingredients, more specifically as medicaments for the treatment of proliferative disorders and pathologic conditions such as, but not limited to, cancer such as leukemia.

  本发明涉及式I、II、III或IV的化合物，和/或其药用可接受的加合物盐和/或其立体异构体和/或其溶剂化合物，式(I)、(II)、(III)和(IV)中R1、R2、R3、R4、R5、R6、R7、R8、R9、R11和R12如权利要求书中所定义或在发明说明书中详细描述的那样，以及使用所述化合物来治疗或预防增殖性疾病以及用于制造治疗或预防增殖性疾病的药物，特别是像白血病这样的癌症。本发明还涉及所述化合物的药物组合物以及使用所述药物组合物来治疗或预防增殖性疾病。本发明还涉及将所述化合物用作生物活性成分，更具体地用作治疗增殖性疾病和病理状况的药物，例如癌症如白血病等。